Work

NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia

Year: 2012

Type: article

Source: Neurobiology of Disease

DOI: 10.1016/j.nbd.2011.12.049

Authors: John A. Saunders, Michael J. Gandal, Steve J. Siegel

Institution: University of Pennsylvania

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Eli Lilly and Company, AstraZeneca, Merck, Sanofi, National Institutes of Health, National Institute of Mental Health, National Institute on Drug Abuse

Awards: G1136351547, Developmental Trajectories of Negative Symptoms in Schizophrenia, Long-term neurobehavioral effects of ketamine exposure in adolescent mice, G2703138655, G3299209112, The Neurobiology of Stimulus Encoding in Schizophrenia

OpenAlex ID: W1991726755

FWCI: 7.358

Cites: 77

Cited by: 89

Related to: 10